PortfoliosLab logoPortfoliosLab logo
FPHAX vs. PGHAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FPHAX vs. PGHAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Putnam Global Health Care Fund (PGHAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FPHAX achieves a 9.07% return, which is significantly higher than PGHAX's -1.12% return.


FPHAX

1D
0.70%
1M
1.26%
YTD
9.07%
6M
8.20%
1Y
42.59%
3Y*
17.70%
5Y*
12.74%
10Y*
12.35%

PGHAX

1D
1.18%
1M
-0.26%
YTD
-1.12%
6M
-1.50%
1Y
17.05%
3Y*
7.58%
5Y*
6.41%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FPHAX vs. PGHAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
FPHAX
Fidelity Select Pharmaceuticals Portfolio
9.07%30.41%9.39%12.54%0.94%11.79%6.91%
PGHAX
Putnam Global Health Care Fund
-1.12%15.58%1.69%9.48%-4.39%19.99%13.35%

Correlation

The correlation between FPHAX and PGHAX is 0.84, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.84

Correlation (3Y)
Calculated over the trailing 3-year period

0.82

Correlation (5Y)
Calculated over the trailing 5-year period

0.85

Correlation (All Time)
Calculated using the full available price history since Jun 1, 2020

0.85

The correlation between FPHAX and PGHAX has been stable across timeframes, ranging from 0.82 to 0.85 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FPHAX vs. PGHAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FPHAX
FPHAX Risk / Return Rank: 6464
Overall Rank
FPHAX Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
FPHAX Sortino Ratio Rank: 6060
Sortino Ratio Rank
FPHAX Omega Ratio Rank: 5050
Omega Ratio Rank
FPHAX Calmar Ratio Rank: 8888
Calmar Ratio Rank
FPHAX Martin Ratio Rank: 6060
Martin Ratio Rank

PGHAX
PGHAX Risk / Return Rank: 2222
Overall Rank
PGHAX Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
PGHAX Sortino Ratio Rank: 2525
Sortino Ratio Rank
PGHAX Omega Ratio Rank: 2020
Omega Ratio Rank
PGHAX Calmar Ratio Rank: 2727
Calmar Ratio Rank
PGHAX Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FPHAX vs. PGHAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Pharmaceuticals Portfolio (FPHAX) and Putnam Global Health Care Fund (PGHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FPHAXPGHAXDifference
Sharpe ratioReturn per unit of total volatility

+0.90

Sortino ratioReturn per unit of downside risk

+1.07

Omega ratioGain probability vs. loss probability

1.36

1.21

+0.14

Calmar ratioReturn relative to maximum drawdown

4.11

1.81

+2.30

Martin ratioReturn relative to average drawdown

11.24

4.47

+6.78

FPHAX vs. PGHAX - Sharpe Ratio Comparison

The current FPHAX Sharpe Ratio is 2.11, which is higher than the PGHAX Sharpe Ratio of 1.21. The chart below compares the historical Sharpe Ratios of FPHAX and PGHAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FPHAX vs. PGHAX - Drawdown Comparison

The maximum FPHAX drawdown since its inception was -38.26%, which is greater than PGHAX's maximum drawdown of -20.52%. Use the drawdown chart below to compare losses from any high point for FPHAX and PGHAX.


Loading charts...

Drawdown Indicators


FPHAXPGHAXDifference

Max Drawdown

Largest peak-to-trough decline

-38.26%

-20.52%

-17.74%

Max Drawdown (1Y)

Largest decline over 1 year

-10.33%

-9.68%

-0.65%

Max Drawdown (3Y)

Largest decline over 3 years

-28.82%

-20.52%

-8.30%

Max Drawdown (5Y)

Largest decline over 5 years

-28.82%

-20.52%

-8.30%

Max Drawdown (10Y)

Largest decline over 10 years

-28.82%

Current Drawdown

Current decline from peak

-3.12%

-5.25%

+2.13%

Average Drawdown

Average peak-to-trough decline

-9.16%

-5.64%

-3.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.77%

3.92%

-0.15%

Volatility

FPHAX vs. PGHAX - Volatility Comparison

Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a higher volatility of 5.87% compared to Putnam Global Health Care Fund (PGHAX) at 5.08%. This indicates that FPHAX's price experiences larger fluctuations and is considered to be riskier than PGHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FPHAXPGHAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.87%

5.08%

+0.79%

Volatility (6M)

Calculated over the trailing 6-month period

14.40%

10.45%

+3.95%

Volatility (1Y)

Calculated over the trailing 1-year period

20.15%

14.51%

+5.64%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.10%

14.45%

+3.65%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

17.90%

14.43%

+3.47%

FPHAX vs. PGHAX - Expense Ratio Comparison

FPHAX has a 0.75% expense ratio, which is higher than PGHAX's 0.72% expense ratio.


Dividends

FPHAX vs. PGHAX - Dividend Comparison

FPHAX's dividend yield for the trailing twelve months is around 5.10%, more than PGHAX's 1.88% yield.


PositionTTM20252024202320222021202020192018201720162015
FPHAX
Fidelity Select Pharmaceuticals Portfolio
5.10%5.68%1.90%8.08%5.18%11.09%8.85%8.33%1.65%1.62%1.07%12.63%
PGHAX
Putnam Global Health Care Fund
1.88%1.86%4.71%5.33%7.48%11.17%8.93%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


FPHAX and PGHAX have a correlation of 0.84, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FPHAX has higher volatility (5.87%) compared to PGHAX (5.08%). In terms of maximum drawdown, FPHAX dropped -38.26% vs PGHAX's -20.52%.

FPHAX currently has the higher Sharpe Ratio (2.11 vs 1.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FPHAX and PGHAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer